FDA Authorizes Pfizer ' s COVID-19 Booster for Children Ages 5 to 11 FDA Authorizes Pfizer ' s COVID-19 Booster for Children Ages 5 to 11

"While it has largely been the case that COVID-19 tends to be less severe in children than adults, the Omicron wave has seen more kids getting sick with the disease and being hospitalized."WebMD Health News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Infectious Diseases News Source Type: news